TARIS Biomedical

About:

TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.

Website: http://www.tarisbiomedical.com

Twitter/X: tarisbio

Top Investors: RA Capital Management, Bristol-Myers Squibb, Polaris Partners, Millhouse, Third Rock Ventures

Description:

TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.

Total Funding Amount:

$113M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)TARISbio.com

Founders:

Paul Janssen

Number of Employees:

11-50

Last Funding Date:

2017-12-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai